Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction.
about
MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitusDifferential regulation of endoplasmic reticulum stress by protein tyrosine phosphatase 1B and T cell protein tyrosine phosphataseMicroRNAs in NF-kappaB signalingβ-Cell MicroRNAs: Small but PowerfulEpigenetics: the missing link to understanding β-cell dysfunction in the pathogenesis of type 2 diabetesMicroRNAs as pharmacological targets in diabetesMicroRNAs: new insights into chronic childhood diseasesInfluence of miRNA in insulin signaling pathway and insulin resistance: micro-molecules with a major role in type-2 diabetesRole of microRNAs in islet beta-cell compensation and failure during diabetesP53/microRNA-34-induced metabolic regulation: new opportunities in anticancer therapyPost-transcriptional regulation in metabolic diseasesMicroRNAs: a new ray of hope for diabetes mellitusThe role of the p53 tumor suppressor in metabolism and diabetesRequirement for distinct vesicle-associated membrane proteins in insulin- and AMP-activated protein kinase (AMPK)-induced translocation of GLUT4 and CD36 in cultured cardiomyocytesEmerging targets in lipid-based therapyArsenic Exposure and Type 2 Diabetes: MicroRNAs as Mechanistic Links?Impact of menopause and diabetes on atherogenic lipid profile: is it worth to analyse lipoprotein subfractions to assess cardiovascular risk in women?A Bioinformatics Approach to the Identification of Variants Associated with Type 1 and Type 2 Diabetes Mellitus that Reside in Functionally Validated miRNAs Binding Sites.MicroRNAs in adipogenesis and as therapeutic targets for obesity.Progression of diet-induced diabetes in C57BL6J mice involves functional dissociation of Ca2(+) channels from secretory vesicles.MicroRNAs in metabolism and metabolic disordersAssociation of microRNA-related gene XPO5 rs11077 polymorphism with susceptibility to thyroid cancer.Glucolipotoxicity of the pancreatic beta cell.Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells.Analyses of copy number variation of GK rat reveal new putative type 2 diabetes susceptibility loci.Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes.Gene-Diet Interactions in Type 2 Diabetes: The Chicken and Egg DebateGene-chip studies of adipogenesis-regulated microRNAs in mouse primary adipocytes and human obesity.Obesity and genetics regulate microRNAs in islets, liver, and adipose of diabetic mice.miRNAs: novel regulators of autoimmunity-mediated pancreatic β-cell destruction in type 1 diabetes.Beta-cell specific deletion of Dicer1 leads to defective insulin secretion and diabetes mellitus.Alteration of microRNA expression correlates to fatty acid-mediated insulin resistance in mouse myoblasts.Comparative microRNA expression profiles of cynomolgus monkeys, rat, and human reveal that mir-182 is involved in T2D pathogenic processesThe complexities of obesity and diabetes with the development and progression of pancreatic cancer.Integrating microRNAs into a system biology approach to acute lung injuryEpigenetic mechanisms in diabetic vascular complications.MicroRNAs in Human Diseases: From Cancer to Cardiovascular Disease.Horizontal transfer of exosomal microRNAs transduce apoptotic signals between pancreatic beta-cells.Targeting microRNAs in obesity.Suppression of endothelial nitric oxide synthase expression and endothelial cell proliferation by an intronic 27-ntmiRNA and it's a novel link to AP-1.
P2860
Q21090997-6BB1733F-272C-4BB6-BF47-162195F8198BQ24336003-7AD9CFB2-A6D0-4A2C-BB80-7C6A37D8AFC6Q24630097-B760658D-3966-46CB-8D8E-2186564ED779Q26780370-F47F33C6-22AA-4560-AB86-E47CC3567717Q26823288-765839F5-0418-4084-B9A3-FFC92A6141C0Q26824024-CE69CA74-0054-4775-8E3B-CD9E7A5B4D09Q26852909-043395B6-E393-4D64-82F1-98F632A94367Q26865641-DCE8E3EF-5B33-46AE-B0CA-38A8FBD5B90FQ26995308-C582889F-857F-41D8-BBE2-F23581F7D278Q27011547-59345B47-F50B-478C-B4E8-CFC53B3BA4F3Q27028039-13AD546E-D353-4CBA-A68C-D4FDD427BCB7Q27028201-0F79C49C-E360-4281-8669-DFC27CF6C7D8Q28079903-C7D4C0A9-1575-429F-B4CE-B7954AD2AF51Q28507590-585B373E-BA59-4269-B02C-766C18058B80Q28655456-54256C36-39B8-4586-9B67-64D8CE3DC295Q29248177-F940049E-715B-4BA4-B98D-5287F6CABE3AQ30234825-7E5CB4E2-D2CF-4A59-9F6C-6F94C69BC441Q30383955-71D1E08F-4A9D-4BD9-8625-80E2AEE279C0Q30400205-DE1FED24-B341-4036-8C31-703F6A14A7E3Q33530805-84C68621-292C-4BC2-91F2-2283B27BA3D2Q33612997-7090AA03-64BE-4185-B3B4-05B96013BB5EQ33621219-DBBA339E-82ED-43E6-BCEF-94AD7BEE819DQ33665283-79730965-7A8E-478F-A7C7-1F29E34241A1Q33750755-8C4EE834-77E2-4BB1-BEE2-253E8CAE5E6DQ33761080-022B3E71-601B-4FA0-A32A-AE311D3BFC04Q33762245-6B5C0CC7-8829-43BA-BB45-4328BB94C410Q33838645-FF262584-6D42-4092-9DBC-21A3BCC90143Q33852650-76B21CCB-5FFE-4ABC-81AA-CB40E3E4AB4AQ33887304-B25CD57F-E9C7-4C6A-99C4-57D01996BDC0Q33920162-A8D6D418-F606-48B3-AADD-FBA1C11E72A8Q34117281-4A351B42-4352-444A-9914-E8BB24A60936Q34156501-4AAD2A52-B496-43B8-B81A-6AF7370EE5C2Q34532789-DC623BDF-8731-49C5-98C0-12D1AE443943Q34669361-E4960E2F-85DA-4BB8-8A05-4424F7EA5F5EQ34778041-C243E342-EC24-4EA1-8752-FAFFE4039802Q34986508-E1DA9B3C-2711-4177-B846-BBD04D746904Q35157020-422F5782-591B-4667-80AE-5520D2007D1FQ35212277-0C7D2DE2-2796-498C-B15B-91486B5AE09EQ35400880-BB2A83A4-2884-4710-B0F4-C5C4F419871EQ35440105-F2ABC66D-331A-49BE-8E38-B16F43159CAD
P2860
Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Alterations in microRNA expres ...... creatic beta-cell dysfunction.
@en
type
label
Alterations in microRNA expres ...... creatic beta-cell dysfunction.
@en
prefLabel
Alterations in microRNA expres ...... creatic beta-cell dysfunction.
@en
P2093
P2860
P356
P1433
P1476
Alterations in microRNA expres ...... creatic beta-cell dysfunction.
@en
P2093
D Ross Laybutt
Elodie Roggli
Jiang-Yan Yang
Pascal Lovis
Romano Regazzi
Sonia Gattesco
P2860
P304
P356
10.2337/DB07-1252
P407
P577
2008-07-15T00:00:00Z